LysoPC(17:0/0:0)
|
Basic information |
| Metabolite name | LysoPC(17:0/0:0) |
 | HMDB0012108 |
 |
C04230 |
 |
24779463 |
| Synonyms | LysoPC(17:0) |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | LysoPC(17:0/0:0) |
| HMDB0012108 |
|
C04230 |
|
24779463 |
| Synonyms | LysoPC(17:0) |
| No. of studies | 10 |
|
Relationship between LysoPC(17:0/0:0) and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M1117 | Type1 | MDD group vs. control group, Russian cohort | Plasma | Human | Down |
| Study M512 | Type1 | CUMS group vs. control group | Plasma | Goto-Kakizaki rat | Down |
| Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Up |
| Study M712 | Type1 | depression group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M767 | Type2 | CUMS + HLJDD group vs. CUMS group | Hippocampus | C57BL/6 mouse | Down |
| Study M774 | Type1 | MDD group vs. control group | Serum | Human | Up |
| Study M775 | Type1 | prenatal stress group vs. control group | Brain | Swiss Webster mouse | Down |
| Study M890 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Down |